MENU

Eureka projects

Pilot scale Production And pre-Market Evaluation of a Cosmetic ingredient from a marine microalga

Secretoneurin (SN): a breakthrough blood biomarker for heart disease and sudden Cardiac Arrest risk

A novel bio-material is to dramatically decrease the cost of treatment of severe wounds and burns.

Bioactive alginates (low guluronate) to be produced in-vivo in bacteria, and by in-vitro epimerisation of high mannuronate alginates from seaweed or bacteria. They will be used for wound healing, health supportive fish feed, fish vaccines and also combined with biopolymers for enhanced performance.
Project ID: 
3354

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.